Annual Working Capital
$170.54 M
+$89.97 M+111.65%
December 31, 2024
Summary
- As of March 14, 2025, SLN annual working capital is $170.54 million, with the most recent change of +$89.97 million (+111.65%) on December 31, 2024.
- During the last 3 years, SLN annual working capital has risen by +$74.50 million (+77.56%).
- SLN annual working capital is now at all-time high.
Performance
SLN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$170.54 M
-$17.61 M-9.36%
December 1, 2024
Summary
- As of March 14, 2025, SLN quarterly working capital is $170.54 million, with the most recent change of -$17.61 million (-9.36%) on December 1, 2024.
- Over the past year, SLN quarterly working capital has dropped by -$29.84 million (-14.89%).
- SLN quarterly working capital is now -19.38% below its all-time high of $211.54 million, reached on March 31, 2024.
Performance
SLN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
SLN Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +111.7% | -14.9% |
| 3 y3 years | +77.6% | -14.9% |
| 5 y5 years | +367.7% | -14.9% |
SLN Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +111.7% | -19.4% | +160.9% |
| 5 y | 5-year | at high | +367.7% | -19.4% | +367.7% |
| alltime | all time | at high | >+9999.0% | -19.4% | >+9999.0% |
Silence Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $170.54 M(+111.7%) | - |
| Dec 2024 | - | $170.54 M(-9.4%) |
| Sep 2024 | - | $188.15 M(-6.1%) |
| Jun 2024 | - | $200.39 M(-5.3%) |
| Mar 2024 | - | $211.54 M(+162.5%) |
| Dec 2023 | $80.58 M(-10.9%) | $80.58 M(-5.1%) |
| Sep 2023 | - | $84.90 M(+7.3%) |
| Jun 2023 | - | $79.16 M(-3.0%) |
| Mar 2023 | - | $81.64 M(-9.7%) |
| Dec 2022 | $90.45 M(-5.8%) | $90.45 M(-7.5%) |
| Sep 2022 | - | $97.74 M(+49.5%) |
| Jun 2022 | - | $65.36 M(-18.7%) |
| Mar 2022 | - | $80.37 M(-16.3%) |
| Dec 2021 | $96.05 M(+38.7%) | $96.05 M(+10.5%) |
| Sep 2021 | - | $86.92 M(-18.0%) |
| Jun 2021 | - | $105.99 M(+53.0%) |
| Dec 2020 | $69.26 M(+89.9%) | $69.26 M(-30.9%) |
| Jun 2020 | - | $100.27 M(+175.0%) |
| Dec 2019 | $36.47 M(+12.0%) | - |
| Dec 2019 | - | $36.47 M(+60.8%) |
| Jun 2019 | - | $22.68 M(-30.4%) |
| Dec 2018 | $32.57 M(-43.8%) | - |
| Dec 2018 | - | $32.57 M(-28.2%) |
| Jun 2018 | - | $45.39 M(-21.7%) |
| Dec 2017 | $57.96 M(+16.3%) | - |
| Dec 2017 | - | $57.96 M(+46.4%) |
| Jun 2017 | - | $39.58 M(-20.6%) |
| Dec 2016 | $49.85 M(-35.8%) | - |
| Dec 2016 | - | $49.85 M(-23.3%) |
| Jun 2016 | - | $64.96 M(-16.4%) |
| Dec 2015 | $77.68 M(+146.8%) | - |
| Dec 2015 | - | $77.68 M(-10.5%) |
| Jun 2015 | - | $86.83 M(+175.9%) |
| Dec 2014 | $31.47 M(-2.4%) | - |
| Dec 2014 | - | $31.47 M(-27.5%) |
| Jun 2014 | - | $43.40 M(+34.6%) |
| Dec 2013 | $32.25 M | - |
| Dec 2013 | - | $32.25 M(-12.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $36.70 M(+180.4%) |
| Dec 2012 | $13.09 M(+219.5%) | - |
| Dec 2012 | - | $13.09 M(>+9900.0%) |
| Jun 2012 | - | $128.80 K(-96.9%) |
| Dec 2011 | $4.10 M(-1.3%) | - |
| Dec 2011 | - | $4.10 M(-47.3%) |
| Jun 2011 | - | $7.77 M(+87.3%) |
| Dec 2010 | $4.15 M(-827.3%) | - |
| Dec 2010 | - | $4.15 M(-40.8%) |
| Jun 2010 | - | $7.02 M(-1329.2%) |
| Dec 2009 | -$570.80 K(-111.2%) | - |
| Dec 2009 | - | -$570.80 K(-111.8%) |
| Jun 2009 | - | $4.86 M(-4.8%) |
| Dec 2008 | $5.10 M(-73.9%) | - |
| Dec 2008 | - | $5.10 M(-56.3%) |
| Jun 2008 | - | $11.68 M(-40.1%) |
| Dec 2007 | $19.52 M(+16.0%) | - |
| Dec 2007 | - | $19.52 M(+76.0%) |
| Jun 2007 | - | $11.09 M(-34.1%) |
| Dec 2006 | $16.83 M(+17.5%) | - |
| Dec 2006 | - | $16.83 M(+37.9%) |
| Jun 2006 | - | $12.20 M(-14.8%) |
| Dec 2005 | $14.32 M(+164.3%) | - |
| Dec 2005 | - | $14.32 M(+335.3%) |
| Jun 2005 | - | $3.29 M(-39.3%) |
| Dec 2004 | $5.42 M(-40.7%) | - |
| Dec 2004 | - | $5.42 M(-10.9%) |
| Jun 2004 | - | $6.08 M(-33.5%) |
| Dec 2003 | $9.15 M(-23.1%) | - |
| Dec 2003 | - | $9.15 M(-8.7%) |
| Jun 2003 | - | $10.02 M |
| Dec 2002 | $11.90 M(-7.7%) | - |
| Dec 2001 | $12.89 M(-21.9%) | - |
| Dec 2000 | $16.50 M(+10.8%) | - |
| Dec 1999 | $14.89 M(+168.7%) | - |
| Dec 1998 | $5.54 M(-27.1%) | - |
| Dec 1997 | $7.60 M(-29.8%) | - |
| Dec 1996 | $10.83 M(+154.0%) | - |
| Dec 1995 | $4.26 M | - |
FAQ
- What is Silence Therapeutics annual working capital?
- What is the all time high annual working capital for Silence Therapeutics?
- What is Silence Therapeutics annual working capital year-on-year change?
- What is Silence Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Silence Therapeutics?
- What is Silence Therapeutics quarterly working capital year-on-year change?
What is Silence Therapeutics annual working capital?
The current annual working capital of SLN is $170.54 M
What is the all time high annual working capital for Silence Therapeutics?
Silence Therapeutics all-time high annual working capital is $170.54 M
What is Silence Therapeutics annual working capital year-on-year change?
Over the past year, SLN annual working capital has changed by +$89.97 M (+111.65%)
What is Silence Therapeutics quarterly working capital?
The current quarterly working capital of SLN is $170.54 M
What is the all time high quarterly working capital for Silence Therapeutics?
Silence Therapeutics all-time high quarterly working capital is $211.54 M
What is Silence Therapeutics quarterly working capital year-on-year change?
Over the past year, SLN quarterly working capital has changed by -$29.84 M (-14.89%)